Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Makoto, Tobiume"'
Physical Exercise Counteracts Aging-Associated White Matter Demyelination Causing Cognitive Decline.
Publikováno v:
Aging & Disease. Oct2024, Vol. 15 Issue 5, p2136-2148. 13p.
Publikováno v:
American Journal of Case Reports. 9/9/2022, Vol. 23, p1-7. 7p.
Autor:
Hisatsugu Goto, Kozo Kagawa, Makoto Tobiume, Daisuke Matsumoto, Hiroshi Nokihara, Yoshimi Bando, Atsuro Saijo, Hiromitsu Takizawa, Yuriko Morikawa, Hiroshi Kawano, Yasuhiko Nishioka, Hirokazu Ogino, Satoshi Sakaguchi
Publikováno v:
Internal Medicine. 61:1393-1397
A 67-year-old man was admitted to our hospital for massive pleural effusion. He had a history of mandibular gingival carcinoma treated with radiation therapy (RT). Based on the cytology findings of pleural effusion and a thoracoscopic pleural biopsy,
Autor:
Makoto, Tobiume, Atsushi, Mitsuhashi, Atsuro, Saijo, Hirokazu, Ogino, Tania, Afroj, Hirohisa, Ogawa, Hisatsugu, Goto, Seidai, Sato, Akane, Abe, Keiko, Haji, Ryohiko, Ozaki, Hiromitsu, Takizawa, Yasuhiko, Nishioka
Publikováno v:
Oncology Letters. 24
Fibrocytes, which are bone marrow-derived collagen-producing cells, have been reported to be involved in pathogenesis of pulmonary fibrosis. Our previous study reported that tumor-infiltrating fibrocytes play a role in tumor progression and drug resi
Autor:
Hisatsugu Goto, Hirokazu Ogino, Atsuro Saijo, Hiroto Yoneda, Hiroyuki Kozai, Masatoshi Kishuku, Masaki Hanibuchi, Atsushi Mitsuhashi, Kazuya Koyama, Kenji Otsuka, Hirohisa Ogawa, Makoto Tobiume, Keisuke Ishizawa, Yasuhiko Nishioka
Publikováno v:
Lung Cancer. 146:86-96
Background: The combination of anti-PD-1/PD-L1 antibody with chemotherapy has been approved for the first-line therapy of lung cancer. However, the effects against malignant mesothelioma (MPM) and the immunological mechanisms by which chemotherapy en
Autor:
Kozo Kagawa, Hiroshi Nokihara, Makoto Tobiume, Hiroshi Kawano, Kenji Otsuka, Hiroto Yoneda, Yasuhiko Nishioka, Hiroyuki Kozai, Tatsuro Saito, Takuya Kuramoto, Yuko Toyoda, Hisatsugu Goto, Masaki Hanibuchi, Hirokazu Ogino, Seidai Sato, Shun Morizumi, Mayo Kondo, Akira Kanoh, Atsuro Saijo
Publikováno v:
Oncotarget
The feasibility and required sensitivity of circulating free DNA (cfDNA)-based detection methods in second-line epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment are not well elucidated. We examined T790M and other activ
Autor:
Atsushi Mitsuhashi, Kazuya Koyama, Kenji Otsuka, Hiroshi Nokihara, Osamu Kondoh, Hirokazu Ogino, Hisatsugu Goto, Makoto Tobiume, Hiroto Yoneda, Masamichi Sugimoto, Yasuhiko Nishioka, Tania Afroj, Na Thi Nguyen, Atsuro Saijo
Publikováno v:
J Immunol
Fibrocytes, a distinct population of collagen-producing, monocyte-derived cells, are involved in wound healing as well as fibrotic diseases. Recently, fibrocytes have been revealed to play a role in the tumor microenvironment, particularly under anti
Autor:
Hisatsugu Goto, Yasuhiko Nishioka, Mayo Kondo, Hiroyuki Kozai, Jun Kishi, Hiroshi Kawano, Yuya Yamashita, Haruka Nishimura, Yuko Toyoda, Makoto Tobiume
Publikováno v:
The Journal of Medical Investigation. 65(1-2):147-150
A 65-year-old female had been treated rheumatoid arthritis (RA), interstitial pneumonia (IP) and nephrotic syndrome with prednisolone and cyclosporine. She was emergently admitted to our hospital due to the worsening exertional dyspnea and severe hyp
Autor:
Hirokazu Ogino, Makoto Tobiume, Kozo Kagawa, Hiroshi Kawano, Satoshi Sakaguchi, Atsuro Saijo, Daisuke Matsumoto, Hiromitsu Takizawa, Yuriko Morikawa, Yoshimi Bando, Hisatsugu Goto, Hiroshi Nokihara, Yasuhiko Nishioka
Publikováno v:
Internal Medicine; 2022, Vol. 61 Issue 9, p1393-1397, 5p
Autor:
Toshihiro Izumi, Licht Miyamoto, Kenji Otsuka, Makoto Tobiume, Yasuhiko Nishioka, Chiemi Sato, Kazuyoshi Kawazoe, Yuki Tsuchihashi, Koichiro Tsuchiya, Naoto Okada, Shinji Abe, Yukinari Kato, Satoshi Ogasawara, Mika K. Kaneko
Publikováno v:
Cancer Science
Podoplanin (aggrus) is highly expressed in several types of cancers, including malignant pleural mesothelioma (MPM). Previously, we developed a rat anti-human podoplanin mAb, NZ-1, and a rat-human chimeric anti-human podoplanin antibody, NZ-8, derive